Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1991
05/08/1991EP0426653A1 4-demethoxy-4-amino-anthracyclines
05/08/1991EP0426574A1 Thiazole derivatives and antiulcer agents containing the same
05/08/1991EP0426573A2 Phenoxypropylamine derivatives or salts thereof and antiulcer agents containing the same
05/08/1991EP0426562A1 1-(4-Aminophenyl)-2-piperidinopropanone derivatives, process for their preparation and their therapeutic use
05/08/1991EP0426557A1 Process for the preparation of 2-(3-pyridyl)-tetrahydrothiopyran-2-carbothiamide-1-(1R,2R)oxydes, the 2-(3-pyridyl)-tetrahydrothiopyran-2-carbothiamide-1-(1R,2R)oxydes and so obtained and pharmaceutical compositions containing them
05/08/1991EP0426521A1 Use of interleukine 2 for the treatment of leukemias
05/08/1991EP0426488A1 Production of modified superoxide dismutase
05/08/1991EP0426479A1 Use of a composition for the manufacture of a medicament for curing the symptoms of overindulgence
05/08/1991EP0426468A2 Stabile polymorphic form of (E)-N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide and the process for its preparation
05/08/1991EP0426467A1 Prodrugs of 6-mercaptopurine and 6-thioguanine
05/08/1991EP0426422A2 Hydrogel wound dressing product
05/08/1991EP0426416A1 Novel morpholinol compounds, their preparation and use
05/08/1991EP0426390A2 Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure
05/08/1991EP0426379A2 Substituted cyclobutenedione compounds
05/08/1991EP0426368A2 Compositions containing derivatives of chitin for preventing adhesion
05/08/1991EP0426225A2 (6,7-dihydro-5H-pyrrolo[1,2-c]-imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
05/08/1991EP0426180A2 Imidazo[4,5-b] quinolinyloxyalkanoic acid amides with enhanced water solubility
05/08/1991EP0426167A2 Antitumor substance, process for preparing the same, and pharmaceutical composition containing the same
05/08/1991EP0426098A1 Phosphate binding agent for oral administration
05/08/1991EP0426075A1 Benzylpyrrolidine derivatives as dopamine agonists
05/08/1991EP0426074A2 Polymer mixtures useful in skin care
05/08/1991EP0426066A2 Ace inhibitors for use for preventing onset of type II diabetes
05/08/1991EP0426029A1 Injectable formulation for lipophilic drugs
05/08/1991EP0426021A1 Condensed imidazole derivatives and processes for preparation thereof
05/08/1991EP0426018A2 Thiophene compounds and their pharmaceutical uses
05/08/1991EP0425968A2 Novel multiple layer transdermal drug administration system
05/08/1991EP0425956A2 ACE inhibitors for use for stabilizing or causing regression of atherosclerosis in coronary arteries
05/08/1991EP0425946A2 Iso- and heterocyclic phenylsulphonamides
05/08/1991EP0425929A1 Process for the preparation of N-(2-hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxy-piperidine and of intermediates
05/08/1991EP0425921A1 Benzimidazole derivatives, their production and use
05/08/1991EP0425909A2 Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor
05/08/1991EP0425906A2 Substituted cycloalkano[b]dihydroindol- and -indolsulfonamides
05/08/1991EP0425902A1 Use of isosorbide 2-mononitrate in the preparation of pharmaceutical compositions for treating angina pectoris
05/08/1991EP0425840A2 Use of methenamine in the treatment of viral diseases and malign neoplasies
05/08/1991EP0425584A1 Prostaglandin-derivatives having antithrombotic activity
05/08/1991EP0425565A1 Silicon compounds in bone treatment.
05/08/1991EP0425541A1 Pyrazolo-azolo-pyrimidine-diones
05/08/1991EP0425507A1 Compositions and methods for treating skin conditions and promoting wound healing.
05/08/1991EP0425505A1 Transdermal antisecretory agents for gastrointestinal disease.
05/08/1991EP0374252A4 Injection-type hemostatic composition
05/08/1991EP0362321A4 Ophthalmic suspensions
05/08/1991CN1051180A Therapeutic nucleosides
05/08/1991CN1051176A Quinolone compounds and process for their preparation
05/08/1991CN1051174A Triazolo derivatives and process for their preparation
05/08/1991CN1051173A Triazolyl hydrazide derivatives and process for their preparation
05/08/1991CA2029222A1 Pyridine derivatives, pharmaceutical compositions containing them and process for preparing same
05/07/1991WO1991006554A1 Nucleoside derivatives
05/07/1991US5013863 Learning enhancement
05/07/1991US5013853 Chroman derivatives
05/07/1991US5013852 Antiinflammatory
05/07/1991US5013845 Condensation reaction, inhibitors of angiotensin converting enzyme
05/07/1991US5013841 Oxo quinoline derivatives
05/07/1991US5013833 Process for preparing cefuroxime axetil
05/07/1991US5013758 Hypotensive, anticoagulant, bronchodilator
05/07/1991US5013757 Physiologically active substance Tan-931, its derivatives, their production and use
05/07/1991US5013756 Catechol derivatives, a process of preparation thereof, and therapeutical compositions containing the same
05/07/1991US5013753 Derivatives of gamma-glutamyl-L-dopa, treatment of Parkinson's disease and cardiovascular diseases
05/07/1991US5013752 Prevention and treatment of alcoholism by the use of dietary chromium
05/07/1991US5013749 Imidazole derivatives and their use as hypercholesterolemia and hyperlipoproteinemia agents
05/07/1991US5013747 Water-soluble antiseptic or antifungal composition
05/07/1991US5013744 Skin disorders
05/07/1991US5013743 Selective antibacterial agent against campytobacter
05/07/1991US5013741 N-[substituted alkylidene]-1,2,3,4-tetrahydro-9-acridinamines useful for enhancing the cholinergic function in a mammal
05/07/1991US5013740 Method for treating emotional numbness and coma
05/07/1991US5013739 Naltrexone, naloxone, herpes, multiple sclerosis, lupus, rheumatoid arthritis
05/07/1991US5013738 L-glutamic acid derivatives
05/07/1991US5013737 2,4,8-Trisubstituted-3H,6H-1,4,5A,8A-tetraazaacenaphtylene-3,5-(4H)-diones and 2,4-8-trisubstituted-4,5-dihydro-5-thioxo-3H,6H-1,4,5A,8A-tetrazaacenaphthylen-3-ones
05/07/1991US5013736 5-lipoxygenase inhibitors, smooth muscle relaxants
05/07/1991US5013735 Method of treating therapy-resistant schizophrenia with amperozide (N-ethyl-4-(4',4'-bis(p-fluorophenyl)butyl)-1-piperazine-carboxamide
05/07/1991US5013734 Novel esters of phenylalkanoic acid
05/07/1991US5013733 Lactam derivatives
05/07/1991US5013731 Bactericides
05/07/1991US5013730 Antibiotics
05/07/1991US5013729 Systemic Bactericides
05/07/1991US5013728 Composition for treating osteoporosis and hormonal imbalance
05/07/1991US5013727 Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
05/07/1991US5013724 Process for the sulfation of glycosaminoglycans, the sulfated glycosaminoglycans and their biological applications
05/07/1991US5013719 Administering cyclosporin A and alpha-difluoromethylornithine
05/07/1991US5013715 Polymethylphenylsiloxane And A Saccharose Fatty Acid Ester; Cosmetic and Medicinal Uses
05/07/1991US5013655 Process for the preparation of colorants or monacolin K in a sterile fluidized bed of low water content
05/07/1991US5013560 Microbially-stable bismuth-containing liquid pharmaceutical suspensions
05/07/1991US5013557 Antiulcer agents
05/07/1991US5013556 Lipids derivatized with polyoxyethylene glycol, drug delivery, antitumor agents
05/07/1991US5013554 Administering antitussive dextrorphan citrate
05/07/1991US5013553 Drug delivery devices
05/07/1991US5013544 Chlorhexidine, nonylphenol/ethylene oxide condensate surfactant, synergistic, spermicidal
05/07/1991US5013541 Poly(alpha-hydroxy acrylic acid) and derivatives as antitartar actives in oral compositions
05/07/1991US5013540 N-Methyl-D-aspartate, neuronal tissue
05/07/1991US5013539 Administering Alpha-Ketoglutaric Acid And Optionally Sodium Thiosulfate
05/07/1991US5013484 Method of treating contact lenses
05/07/1991US5013459 Opthalmic fluid dispensing method
05/07/1991CA2073063A1 Nucleoside derivatives
05/07/1991CA2029338A1 Acat inhibitors
05/07/1991CA2029337A1 Acat inhibitors
05/07/1991CA2029334A1 Morpholine derivatives, their method of preparation and pharmaceutical compositions in which they are present
05/07/1991CA2029282A1 Chemical compounds
05/07/1991CA2029275A1 Aromatic amine compounds, their method of preparation and pharmaceutical compositions in which they are present
05/07/1991CA2028925A1 Substituted n-(imidazolyl)alkyl alanine derivatives
05/07/1991CA2027601A1 Antitumor antibiotic bu-3983t
05/07/1991CA2027377A1 Process for direct isolation of captopril
1 ... 7350 7351 7352 7353 7354 7355 7356 7357 7358 7359 7360 7361 7362 7363 7364 7365 7366 7367 7368 7369 7370 ... 7860